Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The annual National Institute for Health Research (NIHR) Oxford cognitive health Clinical Research Facility (CRF) Open Day, held Tuesday 19 May, was a great success, with patients, public, carers and various teams from across the Oxford Health NHS Foundation Trust and Oxford universities in attendance.

The CRF, which provides a wide range of clinical and scientific resources and patient facilities to enable high quality translational neuroscience studies, invited participants to a variety of talks, interactive sessions and poster presentations.

Mary-Jane Attenburrow, Senior Clinical Research Fellow and Clinical Lead CRF commented: “We were delighted to see so many people visit the CRF for International Clinical Trials Day. One of the presentations was given by a patient who gave a  very powerful, moving  and informative account of the experience of living with bipolar disorder, she has also been actively involved in many research studies.”

In addition, Professor John Geddes, Head of Department of Psychiatry (University of Oxford), Director of Research & Development (Oxford Health NHS Foundation Trust) said of the day:  “The success of the open day – and the increase in scale and attendance since last year - clearly demonstrates that Oxford Health NHS FT is now engaging with research very seriously and with a clear sense of purpose. Working with colleagues across the Academic Health Sciences Centre, NIHR nationally and internationally, I expect a further exponential growth over the forthcoming year – with delivery of real benefits for our patients.”

Links:

Clinical Research Facility (CRF)

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.